C50.9
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - Due to their breast cancer operated patients who have completed further tumor-specific adjuvant or neoadjuvant primary therapy (e.g. chemotherapy, radiation) for at least 6 months (anti-hormonal therapy can be continued). - Age =18 years - The patient must be able to perform the study intervention - Present oral and written consent to participate in the study - Stress loading using a visual analog scale of> 4 (VAS 0-10)
Exclusion criteria
Exclusion criteria: • Known distant metastases • Current chemotherapy, radiotherapy • Severe mental and / or additional organic disease • Clinically relevant cardiac arrhythmias or angina pectoris • Severe pulmonary disease • Inadequate walking ability or gait disorder (including neurological deficits, endoprostheses that lead to gait uncertainty) • Regular meditation practice (several times per week) • Beginning of courses on meditation, relaxation, MBSR, yoga, Qi Gong planned in the next 16 weeks • Planned inpatient, partial or outpatient rehabilitation in the next 16 weeks • Participation in other intervention studies realted to walking or meditation • Insufficient knowledge of the German language
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The aim of the study is to assess the effects of the intervention on different aspects of quality of life and mental condition. Since this is a pilot study, no primary endpoint is defined. | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life (general and disease-specific) on the basis of the World Health Organization Quality of Life - BREF Questionnaire (WHOQOL-BREF) and the Functional Assessment of Cancer Therapy - General Questionnaire (FACT-G) • Perceived Stress Questionnaire (PSQ) • Self-efficacy using the General Self-Efficacy Short-Term Scale (ASKU) • Mindfulness, based on the Freiburg Questionnaire on Mindfulness (FFA) • Anxiety and Depression Scale (HADS) • Pain on the basis of a numerical rating scale • Cancer related fatigue based on the German Cancer Fatigue Scale (CFS-D) in the Havelhöher constitutional questionnaire (S-HKF), version 2.4 • Trait Autonomic Regulation (TaR) in the Havelhöher constitutional questionnaire (T-HKF), version 2.4 Further standardized queries and qualitative surveys related to the intervention: • Satisfaction with the intervention, subjectively perceived effectiveness overall and related to possible side effects / residuals of oncological therapy on the basis of standardized questions and guide-oriented interviews within focus groups in the intervention group. • Feasibility and adherence of the intervention on the basis of the frequency of exercise and intensity documented by the patient in the patient journal and on the basis of guide-based surveys in focus groups in the intervention group | — |
Countries
Germany
Contacts
Institut für Sozialmedizin, Epidemiologie und Gesundheitsökonomie, Charité Universitätsmedizin Berlin